1-6 of 6
Gloria McCormick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Trial of Plerixafor/G-CSF Combined with IV Bu/Flu Conditioning Regimen In AML/MDS Patients Undergoing Allogenic Stem Cell Transplantation

Marina Konopleva, MD, PhD, Zeng Zhihong, Rui-Yu Wang, MD, PhD, Peter F. Thall, PhD, Gloria McCormick, Hongbo Lu, MMSC, Julianne J Chen, Elizabeth J. Shpall, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M Alousi, MD, Uday Popat, MD, Paolo Anderlini, MD, Yago Nieto, MD, PhD, Simrit Parmar, M.D., Becky McMullin, Gabriela Rondon, MD, Wendy D. Schober, Alison Gulbis, Rita Cool, E. Lin, Michael Andreeff, MD, PhD, Richard Champlin
Journal: Blood
Blood (2010) 116 (21): 2358.
https://doi.org/10.1182/blood.V116.21.2358.2358
Published: 2010
Journal Articles

Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study.

Marcos De Lima, Leandro de Padua Silva, Sergio Giralt, Krishna Komanduri, Borje S. Andersson, Chitra Hosing, Muzaffar Qazilbash, Elizabeth Shpall, Peter Thall, Weiqing Zhang, Gloria McCormick, Xuemei Wang, Uday Popat, Andres Soriano, Amin Alousi, Richard Champlin, Guillermo Garcia-Manero
Journal: Blood
Blood (2008) 112 (11): 1134.
https://doi.org/10.1182/blood.V112.11.1134.1134
Published: 2008
Journal Articles

Myeloablative Chemotherapy for T-Cell Lymphoma: a Case for Autologous Stem Cell Transplantatin (Auto) in First Remission.

Issa F Khouri, Adriana Lopez, Grace-Julia Okoroji, Martin Korbling, MD, Gloria McCormick, Yvonne Hsu, Leandro de Padua, Amin M. Alousi, Chitra M. Hosing, Partow Kebriaei, MD, Gabriela Rondon, Sergio A Giralt, MD, Marcos J. de Lima, Paolo Anderlini, Uday R Popat, Muzaffar H. Qazilbash, Richard E. Champlin, Barbara Pro
Journal: Blood
Blood (2008) 112 (11): 1141.
https://doi.org/10.1182/blood.V112.11.1141.1141
Published: 2008
Journal Articles

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Richard E. Champlin, MD, Sergio Giralt, MD, Elizabeth Shpall, MD, Partow Kebriaei, MD, Paolo Anderlini, MD, Muzaffar Qazilbash, MD, John McMannis, PhD, Gloria McCormick, RN, Tobi Fisher, PA, Marcos de Lima, MD, Gabriela Rondon, MD
Journal: Blood
Blood (2007) 110 (11): 1028.
https://doi.org/10.1182/blood.V110.11.1028.1028
Published: 2007
Journal Articles

Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.

Andres O. Soriano, MD, Richard Champlin, MD, Gloria McCormick, Sergio Giralt, MD, Peter Thall, PhD, Krishna Komanduri, MD, Muzaffar Qazilbash, MD, Guillermo Garcia-Manero, MD, Marcos De Lima, MD
Journal: Blood
Blood (2006) 108 (11): 3668.
https://doi.org/10.1182/blood.V108.11.3668.3668
Published: 2006
Journal Articles

Sequential Treatment with Reduced Intensity Allogeneic Stem Cell Transplantation and Imatinib for Chronic Myelogenous Leukemia (CML.

Richard Champlin, M.D., Shubhra Ghosh, M.D., Gloria McCormick, R.N., Borje Andersson, M.D., Ph.D., Marcos de Lima, M.D., Paolo Anderlini, M.D., Muzaffar Qazilbash, M.D., Sergio Giralt, M.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2004) 104 (11): 812.
https://doi.org/10.1182/blood.V104.11.812.812
Published: 2004